SPC TotalMed LP is a private investment fund based in New York, New York. Its most recent Form D, filed Mar 7, 2023, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Justin Wender; Adam Godfrey.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Justin Wender; Adam Godfrey
- Latest Form D
- Mar 7, 2023
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about SPC TotalMed LP
What is the minimum investment for SPC TotalMed LP?
SPC TotalMed LP's latest Form D, filed Mar 7, 2023, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in SPC TotalMed LP?
SPC TotalMed LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has SPC TotalMed LP raised?
SPC TotalMed LP's latest Form D, filed Mar 7, 2023, reports no sales yet.
Where is SPC TotalMed LP based?
SPC TotalMed LP is based in New York, New York.
Size compared with every private investment fund
This fund hasn't reported any sales yet.